The Carlyle Group private equity firm has agreed to acquire the clinical testing division of Johnson & Johnson for $4.15 billion.
The deal for the Ortho-Clinical Diagnostics unit, a NJ-based healthcare screening, diagnosis and monitoring solutions provider, it is expected to close in the middle of this year.
Read the Market Watch press release